See more : Enphys Acquisition Corp. (NFYS-UN) Income Statement Analysis – Financial Results
Complete financial analysis of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (600332.SS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- WCM Beteiligungs- und Grundbesitz-AG (WCMK.DE) Income Statement Analysis – Financial Results
- Croma Security Solutions Group plc (CSSG.L) Income Statement Analysis – Financial Results
- Fondia Oyj (FONDIA.HE) Income Statement Analysis – Financial Results
- Reliant Bancorp, Inc. (RBNC) Income Statement Analysis – Financial Results
- Latin Metals Inc. (LMSQF) Income Statement Analysis – Financial Results
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (600332.SS)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.gybys.com.cn
About Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited, together with its subsidiaries, engages in the research, development, manufacture, and sale of Chinese patent and Western medicines, chemical raw materials, natural and biological medicines, and intermediates of chemical raw materials in the People's Republic of China and internationally. The company operates through four segments: Great Southern TCM, Great Commerce, Great Health, and Others. It is also involved in the wholesale, retail, import, and export of Western and Chinese medicines, and medical apparatus and instruments; and research and development, production, and sale of beverages, food, healthcare products, pre-packaging food, dairy products, tablets, capsules, lozenges, injections, tortoise herb jelly, etc. In addition, the company invests in health industry, such as medical care, health management, health preservation, elderly care, etc.; and provides commercial and advertising services. As of December 31, 2021, it had 154 retail chain pharmacy outlets, which included 22 Cai Zhi Lin pharmacy outlets, 36 Jian Min pharmacy outlets, 51 GPC Prescription Pharmacy outlets, and 23 Hainan Guangyao Chenfei Pharmaceutical Chain Co., Ltd outlets, as well as 22 retail stores. The company was formerly known as Guangzhou Pharmaceutical Company Limited and changed its name to Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited in August 2013. Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited was incorporated in 1997 and is based in Guangzhou, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 75.52B | 70.79B | 69.01B | 61.67B | 64.95B | 42.23B | 20.95B | 20.04B | 19.12B | 18.80B | 17.61B | 8.23B | 5.44B | 4.49B | 3.88B | 3.53B | 12.32B | 10.24B | 9.03B | 7.71B | 6.97B | 5.94B | 5.33B | 4.22B | 3.45B | 3.38B | 3.07B |
| Cost of Revenue | 61.33B | 57.51B | 55.78B | 51.23B | 52.08B | 32.16B | 13.06B | 13.41B | 12.20B | 12.17B | 11.81B | 5.95B | 4.04B | 3.21B | 2.81B | 2.46B | 10.25B | 8.47B | 7.47B | 6.31B | 5.58B | 4.63B | 4.16B | 3.20B | 2.59B | 2.57B | 2.30B |
| Gross Profit | 14.19B | 13.28B | 13.23B | 10.44B | 12.87B | 10.07B | 7.89B | 6.62B | 6.92B | 6.63B | 5.80B | 2.27B | 1.40B | 1.28B | 1.08B | 1.07B | 2.07B | 1.77B | 1.55B | 1.40B | 1.40B | 1.31B | 1.17B | 1.02B | 869.10M | 811.74M | 776.34M |
| Gross Profit Ratio | 18.79% | 18.76% | 19.17% | 16.93% | 19.82% | 23.84% | 37.66% | 33.06% | 36.21% | 35.24% | 32.95% | 27.64% | 25.68% | 28.54% | 27.72% | 30.32% | 16.79% | 17.27% | 17.21% | 18.11% | 20.03% | 22.10% | 21.94% | 24.19% | 25.16% | 23.99% | 25.27% |
| Research & Development | 782.14M | 819.45M | 874.72M | 611.93M | 576.51M | 585.50M | 373.29M | 330.37M | 313.85M | 278.53M | 282.19M | 86.57M | 91.13M | 71.62M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 604.63M | 553.39M | 475.57M | 455.50M | 558.15M | 552.58M | 353.65M | 334.41M | 329.57M | 287.40M | 284.27M | 154.63M | 95.10M | 92.49M | 435.51M | 399.41M | 507.24M | 619.99M | 628.43M | 656.59M | 617.67M | 557.19M | 521.68M | 467.34M | 407.77M | 415.73M | 368.48M |
| Selling & Marketing | 2.76B | 5.88B | 5.95B | 4.58B | 6.38B | 5.06B | 4.29B | 3.82B | 4.17B | 3.94B | 3.49B | 1.36B | 710.83M | 617.32M | 556.48M | 600.67M | 1.02B | 752.59M | 592.21M | 533.61M | 480.11M | 418.08M | 392.78M | 348.17M | 278.47M | 209.08M | 198.08M |
| SG&A | 3.36B | 6.43B | 6.43B | 5.03B | 6.94B | 5.61B | 4.64B | 4.16B | 4.50B | 4.23B | 3.77B | 1.51B | 805.93M | 709.81M | 991.99M | 1.00B | 1.53B | 1.37B | 1.22B | 1.19B | 1.10B | 975.27M | 914.46M | 815.51M | 686.23M | 624.81M | 566.57M |
| Other Expenses | 4.92B | 1.48B | 1.54B | 1.32B | 1.29B | 298.35M | 30.85M | 480.58M | 221.59M | 114.63M | 113.38M | 19.78M | 23.86M | 32.82M | 25.48M | 26.97M | 13.22M | 38.01M | 14.05M | -524.56K | 9.09M | -8.50M | 28.18M | 29.50M | 50.61M | 34.72M | 39.36M |
| Operating Expenses | 9.07B | 8.73B | 8.85B | 6.96B | 8.81B | 7.41B | 5.96B | 5.45B | 5.71B | 5.36B | 4.86B | 2.02B | 1.24B | 1.10B | 1.02B | 1.03B | 1.56B | 1.40B | 1.25B | 1.21B | 1.12B | 999.24M | 936.56M | 835.30M | 704.57M | 639.65M | 581.13M |
| Cost & Expenses | 70.39B | 66.24B | 64.63B | 58.20B | 60.89B | 39.57B | 19.02B | 18.86B | 17.91B | 17.54B | 16.67B | 7.98B | 5.28B | 4.31B | 3.83B | 3.48B | 11.82B | 9.87B | 8.72B | 7.53B | 6.70B | 5.63B | 5.10B | 4.04B | 3.29B | 3.21B | 2.88B |
| Interest Income | 486.34M | 626.79M | 563.87M | 373.87M | 303.22M | 262.00M | 218.82M | 122.19M | 65.05M | 34.70M | 17.73M | 7.55M | 6.59M | 7.12M | 4.12M | 3.72M | 19.30M | 9.07M | 35.43M | 9.33M | 20.50M | 14.28M | 6.32M | 27.16M | -0.18 | -0.43 | -0.01 |
| Interest Expense | 470.09M | 434.41M | 417.83M | 363.34M | 393.65M | 231.58M | 7.12M | 20.68M | 40.71M | 33.57M | 44.50M | 11.69M | 5.82M | 1.99M | 6.72M | 14.95M | 69.33M | 46.85M | 43.10M | 37.87M | 22.20M | 15.33M | 7.20M | 27.91M | 39.89M | 43.16M | 67.14M |
| Depreciation & Amortization | 929.44M | 793.66M | 720.52M | 679.55M | 625.78M | 333.41M | 254.69M | 213.42M | 217.90M | 195.57M | 181.62M | 106.10M | 107.72M | 109.53M | 108.27M | 102.95M | 118.75M | 123.00M | 119.04M | 108.80M | 91.69M | 99.63M | 70.64M | 60.06M | 949.80K | 20.88M | 50.03M |
| EBITDA | 6.46B | 6.15B | 5.76B | 4.45B | 5.04B | 4.27B | 2.74B | 1.99B | 1.69B | 1.56B | 1.25B | 879.75M | 444.26M | 431.32M | 339.74M | 309.88M | 577.52M | 553.59M | 427.15M | 291.09M | 366.62M | 413.77M | 303.78M | 247.12M | 164.53M | 172.08M | 195.21M |
| EBITDA Ratio | 8.55% | 8.87% | 8.61% | 7.92% | 8.06% | 11.30% | 13.20% | 11.03% | 10.07% | 9.40% | 8.36% | 7.07% | 8.29% | 9.75% | 8.46% | 10.21% | 5.55% | 5.28% | 4.73% | 3.78% | 5.26% | 6.96% | 5.70% | 5.81% | 4.76% | 5.10% | 6.38% |
| Operating Income | 5.12B | 5.07B | 4.79B | 3.67B | 4.06B | 3.84B | 2.46B | 1.47B | 1.41B | 1.36B | 1.12B | 438.07M | 308.93M | 298.02M | 207.08M | 176.04M | 460.96M | 373.86M | 300.25M | 178.69M | 298.77M | 313.71M | 261.58M | 200.23M | 163.60M | 151.57M | 146.05M |
| Operating Income Ratio | 6.78% | 7.17% | 6.93% | 5.95% | 6.24% | 9.08% | 11.74% | 7.32% | 7.37% | 7.25% | 6.36% | 5.32% | 5.68% | 6.64% | 5.33% | 4.99% | 3.74% | 3.65% | 3.33% | 2.32% | 4.29% | 5.28% | 4.90% | 4.74% | 4.74% | 4.48% | 4.75% |
| Total Other Income/Expenses | -10.40M | -31.16M | -62.97M | 66.67M | 73.52M | 182.78M | 32.01M | 478.43M | 217.79M | 125.83M | 109.12M | 225.53M | 21.11M | 142.21M | 24.93M | 199.98M | 3.67M | -16.43M | 6.49M | -11.04M | -14.00M | -26.21M | -1.45M | 14.91M | 14.74M | 13.84M | 22.08M |
| Income Before Tax | 5.11B | 5.04B | 4.72B | 3.74B | 4.13B | 4.02B | 2.49B | 1.95B | 1.63B | 1.47B | 1.23B | 457.84M | 334.99M | 321.34M | 231.33M | 202.18M | 472.26M | 370.36M | 306.74M | 167.64M | 284.77M | 287.51M | 260.14M | 219.94M | 178.34M | 165.41M | 168.13M |
| Income Before Tax Ratio | 6.77% | 7.12% | 6.84% | 6.06% | 6.36% | 9.52% | 11.90% | 9.71% | 8.51% | 7.80% | 6.98% | 5.56% | 6.16% | 7.16% | 5.96% | 5.73% | 3.83% | 3.62% | 3.40% | 2.17% | 4.08% | 4.84% | 4.88% | 5.21% | 5.16% | 4.89% | 5.47% |
| Income Tax Expense | 851.17M | 789.87M | 754.09M | 647.45M | 687.25M | 485.01M | 374.22M | 386.38M | 282.84M | 256.53M | 222.24M | 49.51M | 35.00M | 47.31M | 22.57M | 30.21M | 127.61M | 130.83M | 112.61M | 103.57M | 134.43M | 113.12M | 103.21M | 62.73M | 40.67M | 32.23M | 47.37M |
| Net Income | 4.06B | 3.97B | 3.72B | 2.92B | 3.19B | 3.44B | 2.06B | 1.51B | 1.30B | 1.19B | 980.05M | 395.28M | 287.53M | 267.11M | 210.99M | 182.50M | 335.15M | 227.33M | 184.48M | 55.29M | 139.80M | 158.48M | 146.13M | 146.23M | 128.98M | 123.70M | 111.53M |
| Net Income Ratio | 5.37% | 5.60% | 5.39% | 4.73% | 4.91% | 8.15% | 9.84% | 7.53% | 6.80% | 6.34% | 5.57% | 4.80% | 5.29% | 5.95% | 5.44% | 5.17% | 2.72% | 2.22% | 2.04% | 0.72% | 2.01% | 2.67% | 2.74% | 3.46% | 3.73% | 3.66% | 3.63% |
| EPS | 2.49 | 2.44 | 2.29 | 1.79 | 1.96 | 2.12 | 1.27 | 1.08 | 1.01 | 0.93 | 0.77 | 0.58 | 0.36 | 0.33 | 0.26 | 0.23 | 0.41 | 0.29 | 0.23 | 0.07 | 0.17 | 0.20 | 0.18 | 0.19 | 0.16 | 0.15 | 0.14 |
| EPS Diluted | 2.49 | 2.44 | 2.29 | 1.79 | 1.96 | 2.12 | 1.27 | 1.08 | 1.01 | 0.93 | 0.77 | 0.58 | 0.36 | 0.33 | 0.26 | 0.23 | 0.41 | 0.29 | 0.23 | 0.07 | 0.17 | 0.20 | 0.18 | 0.19 | 0.16 | 0.15 | 0.14 |
| Weighted Avg Shares Out | 1.63B | 1.63B | 1.63B | 1.63B | 1.63B | 1.63B | 1.63B | 1.40B | 1.29B | 1.29B | 1.28B | 1.26B | 809.95M | 811.89M | 811.50M | 811.09M | 811.37M | 810.62M | 810.62M | 810.62M | 810.62M | 810.62M | 810.62M | 810.62M | 810.62M | 810.62M | 810.62M |
| Weighted Avg Shares Out (Dil) | 1.63B | 1.63B | 1.63B | 1.63B | 1.63B | 1.63B | 1.63B | 1.40B | 1.29B | 1.29B | 1.28B | 1.26B | 809.95M | 811.89M | 811.50M | 811.09M | 811.37M | 810.62M | 810.62M | 810.62M | 810.62M | 810.62M | 810.62M | 810.62M | 810.62M | 810.62M | 810.62M |
Source: https://incomestatements.info
Category: Stock Reports